Skip to main content
. 2017 Mar 3;2017(3):CD010503. doi: 10.1002/14651858.CD010503.pub2

Comparison 2. Dose comparison: oestrogen 100 µg patch vs 200 µg patch plus progestogen in both groups.

Outcome or subgroup title No. of studies No. of participants Statistical method Effect size
1 Symptoms score: maximum mean daily PDQ 1 98 Mean Difference (IV, Fixed, 95% CI) ‐1.55 [‐8.88, 5.78]
2 Adverse events 1   Risk Ratio (M‐H, Fixed, 95% CI) Subtotals only
2.1 Withdrawal rates 1 107 Risk Ratio (M‐H, Fixed, 95% CI) 0.70 [0.34, 1.46]
2.2 Side effects attributed to oestrogen 1 107 Risk Ratio (M‐H, Fixed, 95% CI) 0.51 [0.26, 0.99]
3 Specific symptoms of PMS 1   Mean Difference (IV, Fixed, 95% CI) Subtotals only
3.1 Psychological symptoms 1 98 Mean Difference (IV, Fixed, 95% CI) ‐0.28 [‐1.17, 0.61]
3.2 Physical symptoms 1 98 Mean Difference (IV, Fixed, 95% CI) ‐0.33 [‐1.17, 0.51]
4 VAS Sense of wellbeing 1 98 Mean Difference (IV, Fixed, 95% CI) 1.70 [‐19.43, 22.83]
5 Patient satisfaction 1 107 Risk Ratio (M‐H, Fixed, 95% CI) 1.19 [0.85, 1.68]
HHS Vulnerability Disclosure